Evidence map›Paper›PMID 34669219›Full record

ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2022

Second dose of COVID-19 vaccination in immediate reactions to the first BNT162b2.

Jaime S Rosa Duque, Daniel Leung, Elaine Y L Au, Yu-Lung Lau

Abstract readLetterComment
In one paragraph

Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Outcomes of pediatric patients with suspected allergies to COVID-19 vaccines.The journal of allergy and clinical immunology. Global · 2025
    Article
  2. Article
  3. The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis.The journal of allergy and clinical immunology. Global · 2023
    Review
  4. Review
  5. Review
  6. Why some people tolerate the second dose of a vaccine but not the first dose.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Jaime S Rosa DuqueDepartment of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.ORCID 0000-0002-5292-5510
Daniel LeungDepartment of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Elaine Y L AuDepartment of Pathology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
Yu-Lung LauDepartment of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.

Funding

Health and Medical Research Fund COVID19F02
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BNT162 VaccineCOVID-19COVID-19 VaccinesHumansSARS-CoV-2VaccinationBNT162 VaccineCOVID-19 VaccinesallergyBNT162b2childrenCOVID-19hypersensitivitypediatricvaccine

Identifiers

PMID34669219
PMCPMC8646469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.